Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jiaoti Huang
Affiliation
Duke University School of Medicine
ORCID
Career Start Year
2000
Papers
294
H Index
69
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38084059
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.
Prostate
2024
36351060
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
Cancer Res
2023
37995683
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
Cancer Cell
2023
37725629
Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers.
PLoS One
2023
36945493
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.
bioRxiv
2023
37012130
Erratum to "Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy" [Eur Urol 2022;81(5):446-55].
Eur Urol
2023
37142586
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Cell Death Dis
2023
37069149
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.
Signal Transduct Target Ther
2023
36963289
Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.
Redox Biol
2023
36724823
Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions.
J Drug Target
2023
36752189
Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
J Pathol
2023
36828904
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.
NPJ Precis Oncol
2023
36629158
The role of glutamine metabolism in castration-resistant prostate cancer.
Asian J Androl
2023
36928314
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
J Clin Invest
2023
34815524
PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer.
Br J Cancer
2022
35674785
Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.
Abdom Radiol (NY)
2022
35394046
Phosphorylated MED1 links transcription recycling and cancer growth.
Nucleic Acids Res
2022
35419594
Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.
Clin Cancer Res
2022
36109521
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.
Nat Commun
2022
35879545
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.
Nat Chem Biol
2022
36282986
<i>Letter to the Editor:</i> mRNA Vaccines in Urological Malignancies.
Hum Gene Ther
2022
35879190
Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion - Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis.
Eur Urol Oncol
2022
36251389
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Cancer Res
2022
35046532
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.
Oncogene
2022
35306527
Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.
Cell Death Dis
2022
35058087
Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
Eur Urol
2022
35027481
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
Mol Cancer Ther
2022
35292724
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Prostate Cancer Prostatic Dis
2022
34675120
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.
Mol Cancer Ther
2022
34591085
A Hybrid Human-Machine Learning Approach for Screening Prostate Biopsies Can Improve Clinical Efficiency Without Compromising Diagnostic Accuracy.
Arch Pathol Lab Med
2022
34645983
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry.
Prostate Cancer Prostatic Dis
2022
34643693
A pleiotropic ATM variant (rs1800057 C>G) is associated with risk of multiple cancers.
Carcinogenesis
2022
32286548
Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.
Prostate Cancer Prostatic Dis
2021
33876838
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
Prostate
2021
33849067
Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.
Nucleic Acids Res
2021
33842835
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.
Precis Clin Med
2021
33564069
Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.
Oncogene
2021
33753479
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Proc Natl Acad Sci U S A
2021
35004332
Glycosylation Changes in Prostate Cancer Progression.
Front Oncol
2021
34591333
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
Prostate
2021
34554200
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.
JAMA Oncol
2021
34732721
Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling.
Nat Commun
2021
34799554
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.
Oncogenesis
2021
33219316
Plectin is a regulator of prostate cancer growth and metastasis.
Oncogene
2021
33398073
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.
Commun Biol
2021
32763316
Urinary Pubic Symphysis Fistula Leads to Histopathologic Osteomyelitis in Prostate Cancer Survivors.
Urology
2021
32589068
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Arch Pathol Lab Med
2021
32948433
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
Urol Oncol
2021
31596671
Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men.
J Urol
2020
31644322
Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.
Arch Pathol Lab Med
2020
1 - 50 of 294
Column Actions
Search
Recommended Authors
Estelle Li
University of British Columbia
Career Start Year
2012
Number of shared co-authors
18
Adam G Sowalsky
National Cancer Institute
Career Start Year
2010
Number of shared co-authors
23
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year
2008
Number of shared co-authors
27
Anne Haegert
University of British Columbia
Career Start Year
2008
Number of shared co-authors
26
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year
2007
Number of shared co-authors
12
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year
2006
Number of shared co-authors
8
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year
2005
Number of shared co-authors
32
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2005
Number of shared co-authors
8
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year
2005
Number of shared co-authors
8
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year
2004
Number of shared co-authors
15
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year
2004
Number of shared co-authors
31
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year
2003
Number of shared co-authors
8
Ashley E Ross
Northwestern University
Career Start Year
2003
Number of shared co-authors
53
Antonio Hurtado-Coll
University of British Columbia
Career Start Year
2002
Number of shared co-authors
23
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year
2002
Number of shared co-authors
28
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
27
Renea A Taylor
Peter MacCallum Cancer Centre
Career Start Year
1999
Number of shared co-authors
9
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year
1999
Number of shared co-authors
24
Hayley C Whitaker
University College London
Career Start Year
1999
Number of shared co-authors
7
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
26
Bhaskar Kallakury
Georgetown University
Career Start Year
1993
Number of shared co-authors
4
Rosina T Lis
National Cancer Institute
Career Start Year
1992
Number of shared co-authors
32
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year
1991
Number of shared co-authors
6
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year
1990
Number of shared co-authors
41
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
11
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
35
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year
1988
Number of shared co-authors
0
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
1987
Number of shared co-authors
25
Beatrice S Knudsen
University of Utah
Career Start Year
1986
Number of shared co-authors
38
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year
1974
Number of shared co-authors
47
row(s) 1 - 30 of 30
Collaborators
Owen N Witte
University of California los angeles
Co-authored papers
35
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers
34
Daniel J Margolis
Weill Cornell Medical College
Co-authored papers
32
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers
20
Martin E Gleave
University of British Columbia
Co-authored papers
19
Eric J Small
University of California san francisco
Co-authored papers
18
Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
17
Rahul Aggarwal
University of California San Francisco
Co-authored papers
17
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers
15
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers
15
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
14
Adam Foye
University of California San Francisco
Co-authored papers
14
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers
13
Christopher P Evans
University of California Davis
Co-authored papers
12
Andrew S Goldstein
University of California los angeles
Co-authored papers
11
David A Quigley
University of California-San Francisco
Co-authored papers
10
Donghui Cheng
University of California los angeles
Co-authored papers
9
Primo N Lara
University of California Davis Comprehensive Cancer Center
Co-authored papers
9
Thomas J George
UF Health Cancer Center
Co-authored papers
7
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Co-authored papers
7
Yiping He
Co-authored papers
7
George V Thomas
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers
7
Clara E Magyar
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers
7
Kim N Chi
University of British Columbia
Co-authored papers
7
Paul Lloyd
Bluestar Genomics Inc.
Co-authored papers
6
William K Oh
Co-authored papers
6
Mark A Rubin
University of Bern
Co-authored papers
6
Adeboye O Osunkoya
Emory University School of Medicine
Co-authored papers
6
Alana S Weinstein
University of California San Francisco
Co-authored papers
6
Yuzhuo Wang
University of British Columbia
Co-authored papers
5
1 - 30